EMEA PoC Diagnostics Market Size Worth $7.4 Billion By 2022

The EMEA PoC diagnostics market is expected to reach USD 7.39 billion by 2022, according to a new report by Grand View Research Inc. 

Incorporation of healthcare IT and telecommunication such as HealthVault concept by Microsoft plays an inevitable role in the development of the Point-of-Care (PoC) diagnostics market. The introduction of healthcare information systems such as Electronic Medical Records (EMR) has highly increased the market penetration rates of these diagnostic tests. 

Rising demand for home healthcare coupled with patient awareness levels and government initiatives aimed at reducing hospital stays and healthcare expenditure are anticipated to drive the Europe, Middle East, and Africa (EMEA) PoC diagnostics market growth. On account of growing demand for self-testing, companies have launched portable devices that are easy to use such as Pandora CDx point-of-care system by POC Medical Systems. 

Growing base of the geriatric population will widen the target consumer base. Aging heightens the risk of chronic diseases including cardiovascular, diabetes, and cancer. Growing base of geriatric population is anticipated to further increase the demand for continuous monitoring via facilities requiring point-of-care diagnostic products such as home healthcare and assisted living facilities. 

 To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/emea-point-of-care-poc-diagnostics-market

Further key findings from the study suggest:

• In 2014, glucose testing dominated the EMEA PoC market with a share of over 60%. Growing prevalence of diabetes and the introduction of portable glucose monitoring devices such as OneTouch, Accu-Chek, and Glucotouch are the major drivers for market growth over the forecast period.

• The infectious disease testing segment is expected to be the fastest-growing product, growing at a CAGR of over8.0% over the next six years. Rising prevalence of infectious disease in low- and middle-income level countries of MEA and Europe is the major aspect accounting for its fastest growth.

• Clinics are likely to account for over 37% of the market by 2022. High procedure volumes associated with clinical establishments is one of the primary reasons attributing to its huge share.

• The home healthcare segment, on the other hand, is expected to grow at a lucrative rate during the forecast period owing to its cost-effectiveness and comfort level it provides to the patients

• Germany held over 19%of the European PoC diagnostics market in 2014.Major factors attributing to growth include the presence of favorable regulations and initiatives undertaken by the government pertaining to the development of healthcare infrastructure and the integration of telecommunications and IT into point-of-care products such as MyGlucoHealth applications.

• South Africa is expected to be the fastest growing segment over the forecast period. High prevalence of malaria and other febrile infectious diseases coupled with huge population base in South Africa are the major factors driving growth of PoC market in this region

• Key market players include Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux S.A., and Alere Inc. 

Grand View Research has segmented the global EMEA PoC diagnostics market on the basis of product, end-use and region:

EMEA Point-of-Care Diagnostics Product Outlook (Revenue, USD Million, 2015 - 2022)

• Glucose testing

  • Over The Counter (OTC)

  • Prescribed

• Cardiac markers

• Fertility

• Blood gas and electrolytes

• Decentralized clinical chemistry

• Infectious disease testing

• CoagulationPrimary care systems

  • Over The Counter (OTC)

  • Prescribed

• Hematology

• Urinalysis

• Drug abuse testing

• Others

EMEA Point-of-Care Diagnostics End-Use Outlook (Revenue, USD Million, 2015 - 2022)

• Hospitals

• Clinics

• Laboratories

• Assisted living healthcare facilities

• Others

EMEA Point-of-Care Diagnostics Regional Outlook (Revenue, USD Million, 2015 - 2022)

• Europe

  • Germany

  • Benelux Union

    • Belgium

    • Netherlands

    • Luxembourg

  • France

  • Spain

  • Portugal

  • Italy

  • Scandinavia

    • Denmark

    • Norway

  • Sweden

  • Finland

  • UK

  • Turkey

  • Rest of Europe

• MEA

  • South Africa

  • Nigeria

  • Kenya

  • Zimbabwe

  • Saudi Arabia

  • United Arab Emirates

  • Qatar

  • Rest of MEA